Four Breast Specimens, One Antibody Panel: Deciding What Can Be Reported
A regional hospital sends eight paraffin blocks from four patients for ER, PR and HER2 testing. The paperwork shows: Patient A - three 16-gauge core biopsies held in saline at room temperature for 3 hours before 10% NBF, total fixation 9 hours. Patient B - lumpectomy, 10% NBF, 68 hours. Patient C - core biopsies in 10% NBF, 96 hours (logged Friday, processed Monday). Patient D - a single core from a rib metastasis decalcified in 10% hydrochloric acid for 90 minutes before processing. Your laboratory's validated fixation window is 6–72 hours in 10% NBF. The pathologist wants the full panel run on everything and asks you to flag any block whose result should not be reported at face value.
1. Triage the four patients. Which blocks are acceptable for ER/PR/HER2 and which are compromised, and on what basis?
Read the worked answer
Judge each specimen against the two independent preanalytic clocks - cold ischemia and fixation time - rather than a single "good/bad" label.
- Patient A: fixation (9 h) is inside the validated 6–72 h window, but 3 h of saline ischemia substantially exceeds the <1 h target. Antigen loss is progressive, so a positive result can be believed, but a negative ER/PR or weak HER2 result is not trustworthy. Run the panel; if results are negative or equivocal, state the ischemic time in the report and recommend repeat sampling.
- Patient B: 68 h is inside the window. Acceptable, no qualifier needed.
- Patient C: 96 h exceeds the upper limit. Over-fixation adds methylene cross-links that heat-induced retrieval may only partially reverse. Staining may be falsely reduced. Run with retrieval, but interpret against strong on-slide controls and comment on prolonged fixation.
- Patient D: acid decalcification is the disqualifier, not the fixation. HCl hydrolyzes nucleic acid and degrades epitopes; HER2 ISH in particular is invalid. IHC may also be attenuated. Do not report HER2 on this block; request an EDTA-decalcified or non-decalcified specimen.
The key judgment is that prolonged ischemia and over-fixation bias results toward false negatives, so only a negative result needs the caveat.
2. Patient C returns ER at 1% weak nuclear staining with a crisp, appropriately stained external control on the same slide. How do you interpret this, and what do you do next?
Read the worked answer
The external control proves the reagents and detection system worked; it does not prove the patient's epitopes survived. With 96 h fixation, the leading competing explanations are (a) genuine low-level ER expression and (b) fixation-related epitope loss producing a falsely low result.
Do not reflexively call it "ER low positive" and move on, and do not reflexively reject it either. Practical steps:
- Confirm the block was sectioned at 4 µm and that the section is representative (no crush or cautery in the counted fields).
- Re-stain with a second ER clone or with an extended retrieval time - concordant low positivity across two clones raises confidence that the result is real.
- Ask whether any other block from the same case exists (excision, prior biopsy) that had shorter fixation.
- Report the percentage and intensity, and explicitly note the 96 h fixation as a limitation affecting sensitivity. Because ER status drives endocrine therapy, the safest report is a qualified one plus a recommendation to test an alternative specimen if one exists.
The reasoning rule: a control validates the run, not the specimen.
3. The clinician calls, angry, saying "the tissue is what it is - just tell me if she's ER positive." What is your communication and documentation plan?
Read the worked answer
Frame the answer around risk of a false negative and the downstream treatment consequence, not around laboratory process.
- Say plainly: the test worked, but the specimen's fixation time can lower ER signal specifically, so a low result may understate the true receptor status and could wrongly deny endocrine therapy.
- Offer options: test a differently fixed block if one exists; repeat the stain with a second clone; or, if the result is discordant with morphology/clinical picture, recommend repeat biopsy.
- Document: the fixation and ischemia times, the qualifier in the report, the person contacted, the time, and the advice given. Note the interpreting pathologist's concurrence.
- Do not release an unqualified ER result over the pathologist's judgment. The laboratory's obligation is to characterize specimen adequacy; the clinician's is to weigh it. If the clinician insists, the final report still carries the caveat - an addendum can capture the discussion but should not delete the limitation.
Boundary-setting language works better than refusing: "Here is what the specimen can and cannot tell us."